Global and China Psychotropic Pharmaceuticals Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Anti-Depressants
1.2.3 Anti-Psychotics
1.2.4 Stimulants
1.2.5 Anxiolytics
1.2.6 Mood Stabilizers
1.3 Market by Application
1.3.1 Global Psychotropic Pharmaceuticals Market Share by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psychotropic Pharmaceuticals Market Perspective (2015-2026)
2.2 Global Psychotropic Pharmaceuticals Growth Trends by Regions
2.2.1 Psychotropic Pharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psychotropic Pharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychotropic Pharmaceuticals Players by Market Size
3.1.1 Global Top Psychotropic Pharmaceuticals Players by Revenue (2015-2020)
3.1.2 Global Psychotropic Pharmaceuticals Revenue Market Share by Players (2015-2020)
3.2 Global Psychotropic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psychotropic Pharmaceuticals Revenue
3.4 Global Psychotropic Pharmaceuticals Market Concentration Ratio
3.4.1 Global Psychotropic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychotropic Pharmaceuticals Revenue in 2019
3.5 Key Players Psychotropic Pharmaceuticals Area Served
3.6 Key Players Psychotropic Pharmaceuticals Product Solution and Service
3.7 Date of Enter into Psychotropic Pharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychotropic Pharmaceuticals Breakdown Data by Type (2015-2026)
4.1 Global Psychotropic Pharmaceuticals Historic Market Size by Type (2015-2020)
4.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Type (2021-2026)
5 Psychotropic Pharmaceuticals Breakdown Data by Application (2015-2026)
5.1 Global Psychotropic Pharmaceuticals Historic Market Size by Application (2015-2020)
5.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Psychotropic Pharmaceuticals Market Size (2015-2026)
6.2 North America Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
6.3 North America Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
6.4 North America Psychotropic Pharmaceuticals Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Psychotropic Pharmaceuticals Market Size (2015-2026)
7.2 Europe Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
7.3 Europe Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
7.4 Europe Psychotropic Pharmaceuticals Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Psychotropic Pharmaceuticals Market Size (2015-2026)
8.2 China Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
8.3 China Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
8.4 China Psychotropic Pharmaceuticals Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Psychotropic Pharmaceuticals Market Size (2015-2026)
9.2 Japan Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
9.3 Japan Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
9.4 Japan Psychotropic Pharmaceuticals Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Psychotropic Pharmaceuticals Market Size (2015-2026)
10.2 Southeast Asia Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
10.3 Southeast Asia Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
10.4 Southeast Asia Psychotropic Pharmaceuticals Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Psychotropic Pharmaceuticals Introduction
11.1.4 Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020))
11.1.5 Teva Pharmaceuticals Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Psychotropic Pharmaceuticals Introduction
11.2.4 Novartis Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
11.2.5 Novartis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Psychotropic Pharmaceuticals Introduction
11.3.4 Mylan Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
11.3.5 Mylan Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Psychotropic Pharmaceuticals Introduction
11.4.4 AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
11.4.5 AstraZeneca Recent Development
11.5 Sun Pharmaceuticals
11.5.1 Sun Pharmaceuticals Company Details
11.5.2 Sun Pharmaceuticals Business Overview
11.5.3 Sun Pharmaceuticals Psychotropic Pharmaceuticals Introduction
11.5.4 Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
11.5.5 Sun Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Anti-Depressants
Table 4. Key Players of Anti-Psychotics
Table 5. Key Players of Stimulants
Table 6. Key Players of Anxiolytics
Table 7. Key Players of Mood Stabilizers
Table 8. Global Psychotropic Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Psychotropic Pharmaceuticals Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Psychotropic Pharmaceuticals Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Psychotropic Pharmaceuticals Market Share by Regions (2015-2020)
Table 12. Global Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Psychotropic Pharmaceuticals Market Share by Regions (2021-2026)
Table 14. Psychotropic Pharmaceuticals Market Market Trends
Table 15. Psychotropic Pharmaceuticals Market Drivers
Table 16. Psychotropic Pharmaceuticals Market Challenges
Table 17. Psychotropic Pharmaceuticals Market Restraints
Table 18. Global Psychotropic Pharmaceuticals Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Psychotropic Pharmaceuticals Market Share by Players (2015-2020)
Table 20. Global Top Psychotropic Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Pharmaceuticals as of 2019)
Table 21. Global Psychotropic Pharmaceuticals by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Psychotropic Pharmaceuticals Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Psychotropic Pharmaceuticals Market Size Share by Type (2015-2020)
Table 27. Global Psychotropic Pharmaceuticals Revenue Market Share by Type (2021-2026)
Table 28. Global Psychotropic Pharmaceuticals Market Size Share by Application (2015-2020)
Table 29. Global Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Psychotropic Pharmaceuticals Market Size Share by Application (2021-2026)
Table 31. North America Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 33. North America Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 35. North America Psychotropic Pharmaceuticals Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Psychotropic Pharmaceuticals Market Share by Country (2015-2020)
Table 37. Europe Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 39. Europe Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 41. Europe Psychotropic Pharmaceuticals Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Psychotropic Pharmaceuticals Market Share by Country (2015-2020)
Table 43. China Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (US$ Million)
Table 44. China Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 45. China Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (US$ Million)
Table 46. China Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 47. China Psychotropic Pharmaceuticals Market Size by Region (US$ Million) (2015-2020)
Table 48. China Psychotropic Pharmaceuticals Market Share by Region (2015-2020)
Table 49. Japan Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 51. Japan Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 53. Japan Psychotropic Pharmaceuticals Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Psychotropic Pharmaceuticals Market Share by Country (2015-2020)
Table 55. Southeast Asia Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 57. Southeast Asia Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 59. Southeast Asia Psychotropic Pharmaceuticals Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Psychotropic Pharmaceuticals Market Share by Country (2015-2020)
Table 61. Teva Pharmaceuticals Company Details
Table 62. Teva Pharmaceuticals Business Overview
Table 63. Teva Pharmaceuticals Product
Table 64. Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (US$ Million)
Table 65. Teva Pharmaceuticals Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Product
Table 69. Novartis Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (US$ Million)
Table 70. Novartis Recent Development
Table 71. Mylan Company Details
Table 72. Mylan Business Overview
Table 73. Mylan Product
Table 74. Mylan Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (US$ Million)
Table 75. Mylan Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Product
Table 79. AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Sun Pharmaceuticals Company Details
Table 82. Sun Pharmaceuticals Business Overview
Table 83. Sun Pharmaceuticals Product
Table 84. Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (US$ Million)
Table 85. Sun Pharmaceuticals Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Psychotropic Pharmaceuticals Market Share by Type: 2020 VS 2026
Figure 2. Anti-Depressants Features
Figure 3. Anti-Psychotics Features
Figure 4. Stimulants Features
Figure 5. Anxiolytics Features
Figure 6. Mood Stabilizers Features
Figure 7. Global Psychotropic Pharmaceuticals Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Retail Stores Case Studies
Figure 11. E-Commerce Case Studies
Figure 12. Psychotropic Pharmaceuticals Report Years Considered
Figure 13. Global Psychotropic Pharmaceuticals Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Psychotropic Pharmaceuticals Market Share by Regions: 2020 VS 2026
Figure 15. Global Psychotropic Pharmaceuticals Market Share by Regions (2021-2026)
Figure 16. Global Psychotropic Pharmaceuticals Market Share by Players in 2019
Figure 17. Global Top Psychotropic Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Pharmaceuticals as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Psychotropic Pharmaceuticals Revenue in 2019
Figure 19. North America Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Teva Pharmaceuticals Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2015-2020)
Figure 47. Novartis Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2015-2020)
Figure 48. Mylan Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2015-2020)
Figure 49. AstraZeneca Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2015-2020)
Figure 50. Sun Pharmaceuticals Revenue Growth Rate in Psychotropic Pharmaceuticals Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed